4 completed, 1 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Recruiting 1 |
Follow Glycemic Control: new trials by email Literature Review of Glycemic Control trials Research Report on Glycemic Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD Ertugliflozin 5 mg, 15mg - Liver Fat, Liver Fibrosis | Phase 4 | Recruiting | Getz Pharma | 164 | 2023-03-01 | 2025-03-21 |
| Metformin to Treat Corticosteroids-induced Hyperglycemia Metformin - Pregnancy Preterm, Glycemic Control | Phase 4 | Completed | The Baruch Padeh Medical Center, Poriya | 187 | 2020-07-05 | 2025-05-09 |
| Dapagliflozin in Type 1 Diabetes Dapagliflozin - Fasting Glucose, Glucose Excursion | Phase 4 | Completed | Medical University Innsbruck | 12 | 2014-08-01 | 2023-03-16 |
| Effect of Immediate Hemoglobin A1c on Glycemic Control in Children With Type I Diabetes Mellitus Bayer DCA2000+ Hemoglobin A1c analyzer - Type 1 Diabetes Mellitus, Glycemic Control | Phase 4 | Completed | Boston Children's Hospital | 234 | 2003-11-01 | 2009-05-12 |
| Tight Glycemic Control Increases Cardiac Stem Cells During Acute Myocardial Infarction Insulin - Myocardial Infarction, Oxidative Stress | Phase 4 | Completed | University of Campania Luigi Vanvitelli | 65 | 2001-01-01 | 2009-03-18 |
Body Weight Changes (1) · Diabetes Mellitus, Type 1 (1) · Fatty Liver (1) · Liver Cirrhosis (1) · Myocardial Infarction (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Autoimmune Diseases (1) · Body Weight (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Fibrosis (1) · Glucose Metabolism Disorders (1) · Heart Diseases (1) · Immune System Diseases (1) · Infarction (1) · Ischemia (1) · Liver Diseases (1)
Insulin (1) · Metformin (1) · dapagliflozin (1) · ertugliflozin (1)
Boston Children's Hospital (1) · Getz Pharma (1) · Medical University Innsbruck (1) · The Baruch Padeh Medical Center, Poriya (1) · University of Campania Luigi Vanvitelli (1)
Austria (1) · Israel (1) · Italy (1) · Pakistan (1) · United States (1)
Markus Laimer, PD MD (1) · Michael SD Agus, MD (1) · Raffaele Marfella, MD, PhD (1) · Umar Raja, MBBS (1)